Thermo Fisher Scientific announced a strong revenue of $11.12 billion for Q3 2025, surpassing analysts' expectations by 1.9% and achieving a year-on-year growth of 4.9%. In response to the positive earnings report, TMO shares increased by 3.6%, contributing to an overall 8.1% rise over the past year. The company's market capitalization stands at $213.34 billion, supported by a robust earnings yield of 3.9%, which outpaces the industry average.
“Thermo Fisher · reported revenues of · Q3 · $11.12 billion”
“Thermo Fisher · surpassed analysts' expectations by · Q3 revenues · 1.9%”
“Thermo Fisher Scientific · reported revenues of · 11.12 billion · up 4.9% year on year”
“Thermo Fisher Scientific · surpassed analysts’ expectations by · 1.9%”
“Thermo Fisher Scientific · reported revenues of · $11.12 billion · up 4.9% year on year”
“Thermo Fisher Scientific · surpassed analysts’ expectations by · 1.9%”
“Thermo Fisher Scientific · stock is up · 3.6%”
“Thermo Fisher Scientific Inc. · announced the enrollment of the first patient in · PPD CorEvitas Alzheimer’s Disease Registry · international, multi-country initiative”
“TMO shares · dipped slightly · 0.03% · last Thursday”
“Thermo Fisher · has a market capitalization of · $213.34 billion”
“Thermo Fisher · has an earnings yield of · 3.9% · well ahead of the industry’s -3.5% yield”
“TMO shares · have risen · 8.1% · compared with the industry’s 1.2% growth”